These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15012991)

  • 21. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
    Johnston IN; Westbrook RF
    Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphine-3-glucuronide--a potent antagonist of morphine analgesia.
    Smith MT; Watt JA; Cramond T
    Life Sci; 1990; 47(6):579-85. PubMed ID: 2402182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not.
    Abrahao KP; Quadros IM; Souza-Formigoni ML
    Neuroscience; 2008 Oct; 156(4):857-64. PubMed ID: 18804151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Four long-acting analgesic hydrazone derivatives of opiates which bind more firmly with opiate receptors].
    Li LY; Ye CY; Zhang ZR; Wang L; Jin YC
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):152-6. PubMed ID: 3017044
    [No Abstract]   [Full Text] [Related]  

  • 25. Morphine-3-glucuronide: silent regulator of morphine actions.
    Lipkowski AW; Carr DB; Langlade A; Osgood PF; Szyfelbein SK
    Life Sci; 1994; 55(2):149-54. PubMed ID: 8015358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
    Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
    J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior.
    Zarrindast MR; Babapoor-Farrokhran S; Babapoor-Farrokhran S; Rezayof A
    Life Sci; 2008 Jun; 82(23-24):1175-81. PubMed ID: 18456284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.
    Eriksen GS; Andersen JM; Boix F; Bergh MS; Vindenes V; Rice KC; Huestis MA; Mørland J
    J Pharmacol Exp Ther; 2016 Aug; 358(2):209-15. PubMed ID: 27278234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors?
    Jacquet YF; Klee WA; Rice KC; Iijima I; Minamikawa J
    Science; 1977 Nov; 198(4319):842-5. PubMed ID: 199942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide.
    Halliday AJ; Bartlett SE; Colditz P; Smith MT
    Life Sci; 1999; 65(2):225-36. PubMed ID: 10416828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret.
    Thompson PI; Bingham S; Andrews PL; Patel N; Joel SP; Slevin ML
    Br J Pharmacol; 1992 May; 106(1):3-8. PubMed ID: 1324067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for sedative effects of low doses of morphine in mice involving receptors insensitive to naloxone.
    Marçais H; Bonnet JJ; Costentin J
    Life Sci; 1981 Jun; 28(24):2737-42. PubMed ID: 6267395
    [No Abstract]   [Full Text] [Related]  

  • 34. The antinociceptive effect of zolpidem and zopiclone in mice.
    Pick CG; Chernes Y; Rigai T; Rice KC; Schreiber S
    Pharmacol Biochem Behav; 2005 Jul; 81(3):417-23. PubMed ID: 15913749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.
    Kotlinska J; Bochenski M; Lagowska-Lenard M; Gibula-Bruzda E; Witkowska E; Izdebski J
    Neuropeptides; 2009 Jun; 43(3):221-8. PubMed ID: 19376576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms.
    Zarrindast MR; Ebrahimi-Ghiri M; Rostami P; Rezayof A
    Behav Brain Res; 2007 Jul; 181(1):35-41. PubMed ID: 17451818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine-6-glucuronide induces contraction of the ileal circular muscle more potently than morphine in mice.
    Iwata H; Tsuchiya S; Ueno K; Nakamura T; Yano S
    Eur J Pharmacol; 2008 Dec; 600(1-3):130-2. PubMed ID: 18930729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the release of endogenous opiates by morphine.
    Dewey WL; Fu TC; Ohlsson A; Bowman E; Martin BR
    NIDA Res Monogr; 1982 Apr; 41():60-6. PubMed ID: 6289120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.